Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
iRay Technology (688301 CH)
Watchlist
39
Analysis
Health Care
•
China
iRay Technology Company Limited manufactures optical components. The Company produces and sells amorphous silicon flat detectors and other products. iRay Technology markets its products throughout China.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Xiamen Amoytop Biotech Co Ltd
•
25 Feb 2025 14:21
Quiddity Leaderboard STAR 50/100 Mar 25: LONGs Up ~12% Vs SHORTs in a Month; More to Come
The STAR50/100 March 2025 index review results will be announced in a few days. Our final expectations for index changes can be found in this...
Janaghan Jeyakumar, CFA
Follow
1.4k Views
Share
bullish
•
Xiamen Amoytop Biotech Co Ltd
•
13 Jan 2025 05:50
STAR50/STAR100 Index Rebalance Preview: Migrations & Outright Changes Lead to Outperformance
There could be 16 changes across the STAR50/100 in March with passives trading nearly US$2bn round-trip. The forecast adds have outperformed the...
Brian Freitas
Follow
914 Views
Share
bullish
•
Xiamen Amoytop Biotech Co Ltd
•
19 Dec 2024 18:27
Quiddity Leaderboard STAR 50/100 Mar25: Multiple Changes, Large Flows; High-Impact Trade Idea
We believe the STAR 50 expected ADDs could continue to outperform the STAR 50 expected DELs over the next few weeks. All of these names have 3.5x...
Janaghan Jeyakumar, CFA
Follow
832 Views
Share
bullish
•
Shanghai Friendess Electronic
•
03 Sep 2023 11:14
China ETFs: Inflows Continue to Support the Market
Money continues to flow into mainland China ETFs with the total inflows since 18 July over US$25bn. This has likely helped stabilise the market and...
Brian Freitas
Follow
739 Views
Share
bullish
•
Piotech
•
28 Aug 2023 05:09
STAR50 Index Rebalance: Two Changes; Pre-Positioning Appears Light
There are 2 changes for the STAR50 in Sep. The adds/dels were expected and there has been big outperformance over the last few weeks. But,...
Brian Freitas
Follow
814 Views
Share
Previous
1
2
3
4
5
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x